News

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it has expanded its previously-announced AdCOVID™ manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated manufacturing suite for clinical and commercial production of AdCOVID, Altimmune’s single-dose intranasal...

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, announced that it is proud to be sponsoring RBQM Live on behalf of the industry. The adoption of Risk-Based Quality Management (RBQM)...

TrialScope, the global leader in clinical trial disclosure and transparency technology, recently added Alexion to its rapidly expanding roster of customers. Alexion joins the ranks of other industry leaders that rely on TrialScope Disclose™ to help manage global clinical trial...

Science 37, the industry leader in decentralized clinical trials, announced today a partnership with Xperiome, a global, rare disease healthtech company. The partnership further strengthens Science 37's capabilities to bring research directly to patients, easing patient's burden and enabling...

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19. Atossa...

Given that the pharmaceutical industry is inherently linked with healthcare and wellness, ensuring high cleanliness standards and that any risks are identified and addressed is vital – the lives of civilians depend upon it. This means that extensive protocols...

Baxter International Inc., a global leader in sterile medication production and delivery, and Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that they have entered into an agreement for Baxter BioPharma Solutions to provide...